3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
21 22 0 0 0 0 0 0 0999 V2000
-1.9859 -1.6685 -0.3363 S 0 0 0 0 0 0 0 0 0 0 0 0
2.9492 -0.4274 1.4407 F 0 0 0 0 0 0 0 0 0 0 0 0
4.7528 0.1368 0.3430 F 0 0 0 0 0 0 0 0 0 0 0 0
3.6248 -1.6248 -0.2897 F 0 0 0 0 0 0 0 0 0 0 0 0
2.7581 0.4591 -0.6586 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.5057 0.0398 0.4480 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.7247 0.7534 0.1543 N 1 0 0 0 0 0 0 0 0 0 0 0
-4.4641 -0.8439 0.1408 N 1 0 0 0 0 0 0 0 0 0 0 0
-0.7619 -0.4543 -0.3129 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3504 0.7828 -0.0334 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6195 -0.5868 -0.5268 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4140 0.5604 -0.4549 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5248 1.9262 0.0335 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8513 1.8016 -0.1786 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1608 -0.4771 0.0179 C 1 0 0 0 0 0 0 0 0 0 0 0
3.5086 -0.3774 0.2130 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0530 -1.5572 -0.7495 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.9539 2.9007 0.2490 H 0 0 0 0 0 0 0 0 0 0 0 0
1.4799 2.6869 -0.1249 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.7580 -1.8094 0.0267 H 0 0 0 0 0 0 0 0 0 0 0 0
-6.0382 0.0002 -0.3646 H 0 0 0 0 0 0 0 0 0 0 0 0
1 9 1 0 0 0 0
1 15 1 0 0 0 0
2 16 1 0 0 0 0
3 16 1 0 0 0 0
4 16 1 0 0 0 0
5 12 1 0 0 0 0
5 16 1 0 0 0 0
6 8 1 0 0 0 0
6 21 1 0 0 0 0
7 10 1 0 0 0 0
7 15 2 0 0 0 0
8 15 1 0 0 0 0
8 20 1 0 0 0 0
9 10 2 0 0 0 0
9 11 1 0 0 0 0
10 13 1 0 0 0 0
11 12 2 0 0 0 0
11 17 1 0 0 0 0
12 14 1 0 0 0 0
13 14 2 0 0 0 0
13 18 1 0 0 0 0
14 19 1 0 0 0 0
M ISO 3 7 15 8 15 15 13
4. 国际命名与标识
4.1 IUPAC Name
N-[6-(trifluoromethoxy)-1,3-benzothiazol-2-yl](15N)hydroxylamine
4.2 InChl
InChI=1S/C8H5F3N2O2S/c9-8(10,11)15-4-1-2-5-6(3-4)16-7(12-5)13-14/h1-3,14H,(H,12,13)/i7+1,12+1,13+1
4.3 InChlKey
MFGRTKLVQQZZIE-VUJIMZNRSA-N
4.4 Canonical SMILES
C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)NO
4.5 lsomeric SMILES
C1=CC2=C(C=C1OC(F)(F)F)S[13C](=[15N]2)[15NH]O
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病